Updates in the Management of Diffuse Large B-Cell Lymphoma
Yazan Samhouri, MD, discusses the latest advancements in the diffuse large B-cell lymphoma treatment landscape.
Significance of the TRIANGLE Study of Frontline Ibrutinib for MCL
Yazan Samhouri, MD, discusses his impressions of the TRIANGLE clinical trial presented at the 2022 American Society of Hematology Annual Meeting.
2 Clarke Drive Cranbury, NJ 08512